Related Experiment Videos
[Angiogenesis as prognostic factor in malignant tumors]
1Klinik für Radio-Onkologie mit Abteilung für Medizinische Strahlenphysik, Universität Bern, Inselspital.
Therapeutische Umschau. Revue Therapeutique
|August 14, 1998
Summary
Angiogenesis, the formation of new blood vessels, is crucial for tumor growth and spread. Targeting this process offers potential new cancer treatments.
Area of Science:
- Oncology
- Cancer Biology
- Vascular Biology
Context:
- Angiogenesis is a fundamental process in tumor progression and metastasis.
- Vascular density and angiogenic factors correlate with cancer patient outcomes.
- Elevated angiogenesis often indicates a poorer prognosis across various cancer types.
Purpose:
- To review the role of angiogenesis in cancer development.
- To explore the link between angiogenic parameters and cancer prognosis.
- To discuss the potential of anti-angiogenic therapies in cancer treatment.
Summary:
- Angiogenesis, or new blood vessel formation, is essential for tumor growth, progression, and metastasis.
- Higher vascular density and increased expression of angiogenic factors are associated with worse outcomes in many cancers.
- Angiogenic activity may also predict response to certain cytotoxic therapies, supporting the development of anti-angiogenic strategies.
Impact:
- Understanding angiogenesis is key to developing novel cancer therapies.
- Anti-angiogenic strategies are being investigated as monotherapy or in combination with traditional treatments.
- Targeting tumor angiogenesis represents a significant therapeutic avenue in oncology.